Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

PHASQ PhaseBio Pharmaceuticals

Watchlist
0.0150.0000.00%
Close  02/07 16:00 ET
High
0.015
Open
0.015
Turnover
20.16
Low
0.015
Pre Close
0.015
Volume
1.36K
Market Cap
737.90K
P/E(TTM)
Loss
52wk High
1.940
Shares
49.86M
P/E(Static)
Loss
52wk Low
0.001
Float Cap
509.28K
Bid/Ask %
0.00%
Historical High
16.650
Shs Float
34.41M
Volume Ratio
0.10
Historical Low
0.001
Dividend TTM
--
Div Yield TTM
--
P/B
-0.01
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.68%
Avg Price
0.014
Lot Size
0
Float Cap
509.28K
Bid/Ask %
0.00%
Historical High
16.650
Shs Float
34.41M
Volume Ratio
0.10
Historical Low
0.001
Dividend TTM
--
P/B
-0.01
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.68%
Avg Price
0.014
Lot Size
0
Price Forecast

News

Comment

Company Overview More
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiovascular diseases. The firm's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor, pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension, and PB6440, an oral agent for the treatment of resistant hypertension. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
CEO: Mr. Jonathan P. Mow
Market: Pink Market
Listing Date: 10/18/2018
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist